切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2019, Vol. 13 ›› Issue (01) : 1 -7. doi: 10.3877/cma.j.issn.1674-3903.2019.01.001

所属专题: 指南与规范 专题评论 文献 指南共识

诊疗规范

中国心脏移植受者术前评估与准备技术规范(2019版)
中华医学会器官移植学分会   
  • 收稿日期:2019-01-17 出版日期:2019-02-25

Technical specification for preoperative evaluation and preparation of heart transplantation recipients in China (2019 edition)

Branch of Organ Transplantation of Chinese Medical Association   

  • Received:2019-01-17 Published:2019-02-25
引用本文:

中华医学会器官移植学分会. 中国心脏移植受者术前评估与准备技术规范(2019版)[J/OL]. 中华移植杂志(电子版), 2019, 13(01): 1-7.

Branch of Organ Transplantation of Chinese Medical Association. Technical specification for preoperative evaluation and preparation of heart transplantation recipients in China (2019 edition)[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2019, 13(01): 1-7.

由于供心资源稀缺,必须对心脏移植候选者进行严格选择,仔细衡量风险和获益,评估其是否适合接受心脏移植。入选心脏移植等待名单的候选者需进行全面的术前评估,最大限度改善心功能和各器官功能状态;同时,接受详细的术前检查,以确保心脏以外器官功能可耐受心脏移植手术及术后免疫抑制治疗。为了进一步规范心脏移植受者选择以及术前评估和准备,中华医学会器官移植学分会组织心脏移植专家,总结相关国内外最新进展,结合国际指南和临床实践,从心脏移植适应证、禁忌证、移植候选者筛选和评估以及术前检查和准备等方面,制订中国心脏移植受者术前评估与准备技术规范(2019版)。

表1 心脏移植适应证
表2 心脏移植禁忌证
绝对禁忌证
? (1)合并系统性疾病,预计生存期<2年,包括活动性/近期发现的实体器官/血液系统恶性肿瘤
? (2)累及多系统的活动性红斑狼疮、结节病或淀粉样变性
? (3)不可逆的肾或肝功能不全且无法行联合移植
? (4)临床症状严重且未能进行血管再通的脑血管疾病
? (5)严重阻塞性肺疾病,FEV1<1 L
? (6)不可逆的肺动脉高压
? ? 肺动脉收缩压>60 mmHg
? ? 平均跨肺动脉压力梯度>15 mmHg
? ? 肺血管阻力>6 Wood单位
相对禁忌证
? (1)年龄>72岁
? (2)任何活动性感染(VAD导致的器械相关性感染除外)
? (3)活动性消化性溃疡
? (4)严重糖尿病并发神经病变、肾病和视网膜病等
? (5)严重的外周和中枢血管疾病
? ? 不能外科手术/介入治疗的外周血管疾病
? ? 有症状的颈动脉狭窄
? ? 未矫正的>6 cm的腹主动脉瘤
? (6)病理性肥胖(体质指数>35 kg/m2)或者恶液质(体质指数<18 kg/m2)
? (7)不可逆的血清肌酐>2.5 mg/dL或肌酐清除率<25 mL/min(心肾联合移植除外)
? (8)总胆红素>2.5 mg/dL,血清转氨酶超过正常值3倍以上,未服用华法林的情况下INR>1.5
? (9)严重肺功能不全,FEV1<40%预计值
? (10)6~8周内发生的肺梗死
? (11)难以控制的高血压
? (12)严重不可逆的神经或神经肌肉疾病
? (13)活动性情感疾病/精神状态不稳定
? (14)6个月内有药物、烟草或酒精滥用史
? (15)100 d内有肝素诱导的血小板减少史
图1 心脏移植候选者筛选流程
图2 心脏移植受者评估流程
表3 心脏移植受者术前危险因素评估
1
Jessup M, Drazner MH, Book W, et al. 2017 ACC/AHA/HFSA/ISHLT/ACP advanced training statement on advanced heart failure and transplant cardiology (Revision on the ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant): a report of the ACC Competency Management Committee[J]. J Am Coll Cardiol, 2017,69(24):2977-3001.
2
Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006[J]. J Heart Lung Transplant, 2006,25(9):1024-1042.
3
Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update[J]. J Heart Lung Transplant, 2016,35(1):1-23.
4
Francis GS, Greenberg BH, Hsu DT,et al. ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: a report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training[J]. Circulation, 2010,122(6):644-672.
5
Barge-Caballero E, Segovia-Cubero J, Almenar-Bonet L, et al. Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry[J]. Circ Heart Fail, 2013,6(4):763-772.
6
Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation[J]. J Heart Lung Transplant, 2018,37(10):1155-1168.
7
Russo MJ, Hong KN, Davies RR, et al. The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines?[J]. Ann Surg, 2010,251(1):144-152.
8
Costanzo MR, Dipchand A, Starling R,et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients[J]. J Heart Lung Transplant, 2010,29(8):914-956.
9
Kotloff RM, Blosser S, Fulda GJ, et al. Management of the potential organ donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organization Consensus Statement[J]. Crit Care Med, 2015,43(6):1291-1325.
10
Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report-2015; Focus Theme: Early Graft Failure[J]. J Heart Lung Transplant, 2015,34(10):1244-1254.
11
Silva Enciso J, Kato TS, Jin Z, et al. Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database)[J]. Am J Cardiol, 2014,114(7):1111-1115.
12
Chung JC, Tsai PR, Chou NK, et al. Extracorporeal membrane oxygenation bridge to adult heart transplantation[J]. Clin Transplant, 2010,24(3):375-380.
13
Jasseron C, Lebreton G, Cantrelle C,et al. Impact of heart transplantation on survival in patients on venoarterial extracorporeal membrane oxygenation at listing in France[J]. Transplantation, 2016,100(9):1979-1987.
14
Marasco SF, Lo C, Murphy D,et al. Extracorporeal life support bridge to ventricular assist device: the double bridge strategy[J]. Artif Organs, 2016,40(1):100-106.
15
Ross HJ, Law Y, Book WM, et al. Transplantation and mechanical circulatory support in congenital heart disease: A scientific statement from the American Heart Association[J]. Circulation, 2016,133(8):802-820.
16
Hu XJ, Dong NG, Liu JP, et al. Status on heart transplantation in China[J]. Chin Med J (Engl), 2015,128(23):3238-3242.
17
Mancini D, Lietz K. Selection of cardiac transplantation candidates in 2010[J]. Circulation, 2010,122(2):173-183
18
Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America[J]. J Am Coll Cardiol, 2017,70(6):776-803.
19
Riccio C Coordinator, Gulizia MM Facc Fesc Coordinator, Colivicchi F Facc Fesc Coordinator, et al. ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy[J]. Eur Heart J Suppl, 2017,19(Suppl D):D163-D189.
20
Authors/Task Force members, Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2014,35(39):2733-2779.
21
Li F, Cai J, Sun YF, et al. Pediatric heart transplantation: report from a single center in China[J]. Chin Med J (Engl), 2015,128(17):2290-2294.
22
Lee SJ, Kim KH, Hong SK, et al. Evaluation of a heart transplant candidate[J]. Curr Cardiol Rep, 2017,19(12):133.
[1] 周容, 张亚萍, 廖宇, 程晓萍, 管玉龙, 潘广玉, 闫杰, 王贤芝, 苟中山, 潘登科, 李巅远. 超声在基因编辑猪-猴异种并联式心脏移植术中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 617-623.
[2] 庄燕, 戴林峰, 张海东, 陈秋华, 聂清芳. 脓毒症患者早期生存影响因素及Cox 风险预测模型构建[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 372-378.
[3] 黄鸿初, 黄美容, 温丽红. 血液系统恶性肿瘤患者化疗后粒细胞缺乏感染的危险因素和风险预测模型[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 285-292.
[4] 罗文斌, 韩玮. 胰腺癌患者首次化疗后中重度骨髓抑制的相关危险因素分析及预测模型构建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 357-362.
[5] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[6] 林凯, 潘勇, 赵高平, 杨春. 造口还纳术后切口疝的危险因素分析与预防策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 634-638.
[7] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[8] 周艳, 李盈, 周小兵, 程发辉, 何恒正. 不同类型补片联合Nissen 胃底折叠术修补食管裂孔疝的疗效及复发潜在危险因素[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 528-533.
[9] 周迪, 全志伟. 规范化胆囊良性疾病诊治流程减少胆囊癌误诊误治[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 749-753.
[10] 林科灿, 罗柳平. 肝胰十二指肠切除术在胆囊癌和胆管癌应用中的关键问题[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 774-778.
[11] 司楠, 孙洪涛. 创伤性脑损伤后肾功能障碍危险因素的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 300-305.
[12] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[13] 李文哲, 王毅, 崔建, 郑启航, 王靖彦, 于湘友. 新疆维吾尔自治区重症患者急性肾功能异常的危险因素分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 269-276.
[14] 刘志超, 胡风云, 温春丽. 山西省脑卒中危险因素与地域的相关性分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 424-433.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?